Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) bought by Moors & Cabot Inc.

Moors & Cabot Inc. raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report ) by 2.4% in the second quarter, according to its most recent filing with the SEC. The fund owned 6,937 shares of the exchange traded fund’s stock after acquiring an additional 162 shares during the period. The holdings of Moors & Cabot Inc. holdings in SPDR S&P Biotech ETF were worth $643,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have recently modified their holdings of the company. ICA Group Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $27,000. Scarborough Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $32,000. BOCHK Asset Management Ltd purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $36,000. ORG Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at $40,000. Finally, Vima LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $45,000.

SPDR S&P Biotech ETF trading up 1.6%

Shares of NYSEARCA:XBI opened at $102.43 on Friday. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The company has a fifty day simple moving average of $98.88 and a 200 day simple moving average of $93.92. The firm has a market cap of $7.81 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

About the SPDR S&P Biotech ETF

(Free report)

The SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. S&P TMI tracks all US common stocks listed on the New York Stock Exchange, the American Stock Exchange, the National Automated Quotation Market of the National Association of Securities Dealers (NASDAQ) and the NASDAQ Small Cap exchanges.

Featured stories

Want to see what other hedge funds own XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).

Get daily news and ratings for the SPDR S&P Biotech ETF – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com’s FREE daily email newsletter.